Anti-NDUFC2-KCTD14 monoclonal antibody

Pre-made anti-NDUFC2-KCTD14 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NDUFC2-KCTD14/NDUFC2-KCTD14 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1263-Ab-1/ GM-Tg-hg-IP1263-Ab-2Anti-Human NDUFC2-KCTD14 monoclonal antibodyHuman
GM-Tg-rg-IP1263-Ab-1/ GM-Tg-rg-IP1263-Ab-2Anti-Rat NDUFC2-KCTD14 monoclonal antibodyRat
GM-Tg-mg-IP1263-Ab-1/ GM-Tg-mg-IP1263-Ab-2Anti-Mouse NDUFC2-KCTD14 monoclonal antibodyMouse
GM-Tg-cynog-IP1263-Ab-1/ GM-Tg-cynog-IP1263-Ab-2Anti-Cynomolgus/ Rhesus macaque NDUFC2-KCTD14 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1263-Ab-1/ GM-Tg-felg-IP1263-Ab-2Anti-Feline NDUFC2-KCTD14 monoclonal antibodyFeline
GM-Tg-cang-IP1263-Ab-1/ GM-Tg-cang-IP1263-Ab-2Anti-Canine NDUFC2-KCTD14 monoclonal antibodyCanine
GM-Tg-bovg-IP1263-Ab-1/ GM-Tg-bovg-IP1263-Ab-2Anti-Bovine NDUFC2-KCTD14 monoclonal antibodyBovine
GM-Tg-equg-IP1263-Ab-1/ GM-Tg-equg-IP1263-Ab-2Anti-Equine NDUFC2-KCTD14 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1263-Ab-1/ GM-Tg-hg-IP1263-Ab-2; GM-Tg-rg-IP1263-Ab-1/ GM-Tg-rg-IP1263-Ab-2;
GM-Tg-mg-IP1263-Ab-1/ GM-Tg-mg-IP1263-Ab-2; GM-Tg-cynog-IP1263-Ab-1/ GM-Tg-cynog-IP1263-Ab-2;
GM-Tg-felg-IP1263-Ab-1/ GM-Tg-felg-IP1263-Ab-2; GM-Tg-cang-IP1263-Ab-1/ GM-Tg-cang-IP1263-Ab-2;
GM-Tg-bovg-IP1263-Ab-1/ GM-Tg-bovg-IP1263-Ab-2; GM-Tg-equg-IP1263-Ab-1/ GM-Tg-equg-IP1263-Ab-2
Products NameAnti-NDUFC2-KCTD14 monoclonal antibody
Formatmab
Target NameNDUFC2-KCTD14
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NDUFC2-KCTD14 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1263-Ag-1Recombinant multi-species NDUCR/ NDUFC2-KCTD14 protein


    Target information

    Target IDGM-IP1263
    Target NameNDUFC2-KCTD14
    Gene ID100532726
    Gene Symbol and SynonymsNDUFC2-KCTD14
    Uniprot AccessionE9PQ53
    Uniprot Entry NameNDUCR_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000259112
    Target ClassificationN/A

    The target: NDUFC2-KCTD14, gene name: NDUFC2-KCTD14, also named as . This locus represents naturally occurring read-through transcription between the neighboring NDUFC2 (NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa) and KCTD14 (potassium channel tetramerisation domain containing 14) genes on chromosome 11. The read-through transcripts share sequence identity with the upstream gene product and one variant has a frameshifted C-terminal region derived from the downstream gene exons. [provided by RefSeq, Feb 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.